Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1991-11-6
|
pubmed:abstractText |
In order to identify cell-substrate adhesion receptors on vascular endothelium, murine monoclonal antibodies (MoAb) were raised against human umbilical vein endothelial cells (HUVE). One anti-HUVE MoAb, RMAC11, identified the adhesion receptor VLA-2 as it immunoprecipitated a non-covalently linked heterodimer of 160 kD and 130 kD, which was identical to the heterodimer immunoprecipitated by the anti-VLA-2 MoAb, 12F1 and 5E8. Furthermore, proteolytic peptide maps of the VLA-2 alpha- and beta-chains were highly homologous with those of the RMAC11-recognized molecule. However, unlike other VLA-2 MoAb, RMAC11 also identified an 85 kD band which migrated to 90 kD under reducing conditions. This band was most likely a fragment of the 160 kD alpha-chain as a similar alpha-chain derived fragment has been demonstrated in the immunoprecipitates of some VLA-4 reactive monoclonals. However the possibility that this may be a novel molecule associated with VLA-2 has not been excluded. In vitro assays of HUVE adhesion to collagen types 1 and 4, laminin and fibronectin showed that RMAC11 blocked adhesion to collagen (types 1 and 4) and laminin, but had no effect on HUVE adhesion to fibronectin, confirming that VLA-2 is a collagen and laminin receptor for HUVE.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen,
http://linkedlifedata.com/resource/pubmed/chemical/Laminin,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cell Surface,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Collagen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Very Late Antigen
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0818-9641
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
69 ( Pt 2)
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
103-10
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1655641-Antibodies, Monoclonal,
pubmed-meshheading:1655641-Cell Adhesion,
pubmed-meshheading:1655641-Collagen,
pubmed-meshheading:1655641-Endothelium, Vascular,
pubmed-meshheading:1655641-Female,
pubmed-meshheading:1655641-Humans,
pubmed-meshheading:1655641-Infant, Newborn,
pubmed-meshheading:1655641-Laminin,
pubmed-meshheading:1655641-Peptide Mapping,
pubmed-meshheading:1655641-Precipitin Tests,
pubmed-meshheading:1655641-Pregnancy,
pubmed-meshheading:1655641-Receptors, Cell Surface,
pubmed-meshheading:1655641-Receptors, Collagen,
pubmed-meshheading:1655641-Receptors, Very Late Antigen,
pubmed-meshheading:1655641-Umbilical Cord
|
pubmed:year |
1991
|
pubmed:articleTitle |
VLA-2 is a collagen receptor on endothelial cells.
|
pubmed:affiliation |
Department of Nephrology, Royal Melbourne Hospital, Victoria, Australia.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|